Activite Tablets

Adult dose

For individuals aged 12 and older: 1 tablet once a day after meals

This medication should not be taken by patients with hypercalcemia, sarcoidosis, or renal disorders. Individuals allergic to this medication or its components should also avoid it. This medication should not be used by infants under 12 months old or patients with kidney stones. During the use of this medication, phosphates, calcium salts, oral tetracyclines, antacids, and drugs such as levodopa should not be taken together. Patients under 1 year of age, those undergoing treatment, children exposed to direct sunlight while maintaining a normal diet, patients with hyperoxaluria, pregnant or breastfeeding women, premature infants, infants, patients with heart or circulatory issues, those with kidney impairment, patients with hypoproteinemia, or those with history of gout or kidney stones should consult a doctor or pharmacist before taking this medication. If symptoms such as nausea, vomiting, diarrhea, abdominal discomfort, constipation, skin rashes, hypotension, digestive disorders, or pulmonary edema occur while taking this medication, it should be immediately discontinued and an expert should be consulted. Additionally, if menstruation becomes frequent or heavy, discontinuation and consultation are necessary. Women taking estrogen-containing oral contraceptives or patients with thrombotic predispositions may have an increased risk of thrombosis when taking this medication. Long-term high-dose use can lead to tolerance, and certain vitamins can cause neuropathy or hematological abnormalities, so caution is needed. High-dose use may induce peptic ulcers, glucose intolerance, hyperuricemia, and liver damage. Caution should be exercised as overdose may lead to nausea, vomiting, edema, congestive heart failure, and high-potassium levels if taken with certain diuretics. If symptoms do not improve after taking for over a month, consult a specialist. This medication must be strictly used according to the prescribed dosage, and when administered to children, adult supervision is required. Additionally, this medication may affect blood glucose testing during urinalysis and could change urine color to yellow, potentially affecting test results. It is advisable to avoid teas containing tannins, such as green tea or black tea, during and immediately before or after taking this medication. Store this medication in a tightly sealed container, protecting it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Serious side effects

• Rash
• pulmonary edema
• edema

Mild side effects

Nausea, vomiting, diarrhea, abdominal discomfort, constipation, rash, redness, loose stools, hypotension, gastrointestinal distress, digestive issues, upper abdominal pain, pulmonary edema, changes in menstrual cycle such as increased frequency or quantity, bleeding, sensory neuropathy, neurological symptoms, hematological abnormalities, hyperuricemia, liver damage, hypernatremia, congestive heart failure, edema, hyperkalemia

Drug interactions

This medication should not be taken simultaneously with phosphates, calcium salts, oral tetracycline preparations, antacids, or levodopa. Also, consultations should be made with a doctor or pharmacist when taken alongside estrogen-containing oral contraceptives, anti-aldosterone agents, or triamterene.

Food interactions

This medication has interactions with teas containing tannins, such as green tea or black tea, both during use or immediately before and after.

This medication should be stored in a tightly sealed container to protect it from air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Red-brown oval film-coated tablet

Package unit

60 tablets/bottle, 120 tablets/bottle [(60 tablets/bottle × 2)]